The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy

Despite the progress achieved in breast cancer screening and therapeutic innovations, the basal-like subtype of breast cancer (BLBC) still represents a particular clinical challenge. In order to make an impact on survival in this type of aggressive breast cancer, new targeted therapeutic agents are urgently needed. Aberrant activation of the Hedgehog (Hh) signalling pathway has been unambiguously tied to cancer development and progression in a variety of solid malignancies, and the recent approval of vismodegib, an orally bioavailable small-molecule inhibitor of Smoothened, validates Hh signalling as a valuable therapeutic target. A number of recent publications have highlighted a role for Hh signalling in breast cancer models and clinical specimens. Interestingly, Hh ligand overexpression is associated with the BLBC phenotype and a poor outcome in terms of metastasis and breast cancer-related death. In this review, we provide a comprehensive overview of the canonical Hh signalling pathway in mammals, highlight its roles in mammary gland development and breast carcinogenesis and discuss its potential therapeutic value in BLBC.

[1]  Tannishtha Reya,et al.  Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia , 2009, Nature.

[2]  R. Samant,et al.  Hedgehog Signaling in Tumor Cells Facilitates Osteoblast-Enhanced Osteolytic Metastases , 2012, PloS one.

[3]  T. Fleming,et al.  Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. , 2001, The New England journal of medicine.

[4]  Ping Xu,et al.  Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding. , 2008, Developmental cell.

[5]  I. Vořechovský,et al.  A Mammalian patched Homolog Is Expressed in Target Tissues of sonic hedgehog and Maps to a Region Associated with Developmental Abnormalities (*) , 1996, The Journal of Biological Chemistry.

[6]  A. Rocha,et al.  Distinct stem cells contribute to mammary gland development and maintenance , 2011, Nature.

[7]  P. Lichter,et al.  Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue. , 2005, Cancer research.

[8]  Roman K. Thomas,et al.  A crucial requirement for Hedgehog signaling in small cell lung cancer , 2011, Nature Medicine.

[9]  A. Ballester,et al.  Intraepithelial paracrine Hedgehog signaling induces the expansion of ciliated cells that express diverse progenitor cell markers in the basal epithelium of the mouse mammary gland. , 2012, Developmental biology.

[10]  G. Page,et al.  Hedgehog signaling and response to cyclopamine differs in epithelial and stromal cells in benign breast and breast cancer , 2006, Cancer biology & therapy.

[11]  Haiyan I. Li,et al.  Purification and unique properties of mammary epithelial stem cells , 2006, Nature.

[12]  M. Kadakia,et al.  p63 Overexpression Induces the Expression of Sonic Hedgehog , 2006, Molecular Cancer Research.

[13]  R. Samant,et al.  Hedgehog Signaling Induced by Breast Cancer Cells Promotes Osteoclastogenesis and Osteolysis* , 2010, The Journal of Biological Chemistry.

[14]  G. Dontu,et al.  Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. , 2006, Cancer research.

[15]  L. Matrisian,et al.  TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling. , 2011, Cancer research.

[16]  Aleksandar Sekulic,et al.  Efficacy and safety of vismodegib in advanced basal-cell carcinoma. , 2012, The New England journal of medicine.

[17]  P. Beachy,et al.  Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector , 2010, Proceedings of the National Academy of Sciences.

[18]  S. Hilsenbeck,et al.  Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation and ductal dysplasia , 2007, Development.

[19]  C. Watson,et al.  Mammary development in the embryo and adult: a journey of morphogenesis and commitment , 2008, Development.

[20]  S. Fox,et al.  Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers , 2009, Nature Medicine.

[21]  A. Ruiz i Altaba,et al.  Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion , 2009, EMBO molecular medicine.

[22]  P. Schofield,et al.  Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancer. , 2011, Cancer research.

[23]  M. Scott,et al.  Basal cell carcinomas in mice overexpressing sonic hedgehog. , 1997, Science.

[24]  C. Hui,et al.  Shh expression is required for embryonic hair follicle but not mammary gland development. , 2003, Developmental biology.

[25]  Masao Tanaka,et al.  Hedgehog signaling pathway mediates the progression of non‐invasive breast cancer to invasive breast cancer , 2011, Cancer science.

[26]  S. K. Zaidi,et al.  Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells. , 2008, Cancer research.

[27]  M. Kleman,et al.  Targeted Expression of GLI1 in the Mammary Gland Disrupts Pregnancy-induced Maturation and Causes Lactation Failure* , 2007, Journal of Biological Chemistry.

[28]  R. Samant,et al.  Hedgehog Signaling: Networking to Nurture a Promalignant Tumor Microenvironment , 2011, Molecular Cancer Research.

[29]  Jussi Taipale,et al.  Hedgehog: functions and mechanisms. , 2008, Genes & development.

[30]  Stuart L. Schreiber,et al.  A small molecule that binds Hedgehog and blocks its signaling in human cells , 2009, Nature chemical biology.

[31]  Jeremy Stinson,et al.  Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. , 2009, The New England journal of medicine.

[32]  Ming Zhao,et al.  The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells. , 2006, Cancer research.

[33]  Ida M. Washington,et al.  Dose- and route-dependent teratogenicity, toxicity, and pharmacokinetic profiles of the hedgehog signaling antagonist cyclopamine in the mouse. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[34]  Mark T. W. Ebbert,et al.  Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes , 2011, Nature Medicine.

[35]  Karen Gelmon,et al.  Metastatic behavior of breast cancer subtypes. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  Masatoshi Nomura,et al.  Hedgehog Signaling Pathway is a New Therapeutic Target for Patients with Breast Cancer , 2004, Cancer Research.

[37]  I. Vořechovský,et al.  The patched/hedgehog/smoothened signalling pathway in human breast cancer: no evidence for H133Y SHH, PTCH and SMO mutations. , 1999, European journal of cancer.

[38]  Barbara Stecca,et al.  Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways , 2007, Proceedings of the National Academy of Sciences.

[39]  William C Hines,et al.  Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression , 2011, Nature Medicine.

[40]  Y. Xuan,et al.  Expression of Indian Hedgehog signaling molecules in breast cancer , 2009, Journal of Cancer Research and Clinical Oncology.

[41]  Mark G. F. Sun,et al.  Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade , 2009, Proceedings of the National Academy of Sciences.

[42]  D. Jenkins.  Hedgehog signalling: emerging evidence for non-canonical pathways. , 2009, Cellular signalling.

[43]  P. Beachy,et al.  Teratogen-mediated inhibition of target tissue response to Shh signaling. , 1998, Science.

[44]  Li-hui Wang,et al.  Expression and regulation mechanisms of Sonic Hedgehog in breast cancer , 2010, Cancer science.

[45]  B. Rozell,et al.  Development of mammary tumors by conditional expression of GLI1. , 2009, Cancer research.

[46]  A. Ashworth,et al.  BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. , 2010, Cell stem cell.

[47]  C. Sugnet,et al.  Defects in mouse mammary gland development caused by conditional haploinsufficiency of Patched-1. , 1999, Development.

[48]  Stephen Gould,et al.  Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells , 2011, Proceedings of the National Academy of Sciences.

[49]  A. McMahon,et al.  Abnormal Hair Development and Apparent Follicular Transformation to Mammary Gland in the Absence of Hedgehog Signaling , 2007, Developmental cell.

[50]  Hua Tian,et al.  A paracrine requirement for hedgehog signalling in cancer , 2008, Nature.

[51]  Hong Chang,et al.  Ptch1 is required locally for mammary gland morphogenesis and systemically for ductal elongation , 2009, Development.

[52]  Joel Greshock,et al.  High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization , 2005, Breast Cancer Research.

[53]  L. Pannell,et al.  INCREASED VASCULARITY AND SPONTANEOUS METASTASIS OF BREAST CANCER BY HEDGEHOG SIGNALING MEDIATED UPREGULATION OF CYR61 , 2011, Oncogene.

[54]  Jun O. Liu,et al.  Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth. , 2010, Cancer cell.

[55]  Monika Engelhardt,et al.  Essential role of stromally induced hedgehog signaling in B-cell malignancies , 2007, Nature Medicine.

[56]  J. Rosen,et al.  Altered differentiation and paracrine stimulation of mammary epithelial cell proliferation by conditionally activated Smoothened. , 2011, Developmental biology.

[57]  Yuanzhi Lu,et al.  Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway. , 2012, Cancer research.

[58]  M. Noll,et al.  The Drosophila smoothened Gene Encodes a Seven-Pass Membrane Protein, a Putative Receptor for the Hedgehog Signal , 1996, Cell.

[59]  A. Groß.  The Global Economic Cost of Cancer: Improving Outcomes and Cost by Reducing International Barriers to Care , 2015 .

[60]  C. Sugnet,et al.  The Gli2 transcription factor is required for normal mouse mammary gland development. , 2001, Developmental biology.

[61]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[62]  Gerald C. Chu,et al.  GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. , 2009, Genes & development.

[63]  Y Wang,et al.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[64]  J. Schneider,et al.  Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment. , 2012, Cancer research.

[65]  G. Moreno-Bueno,et al.  Correlation of Snail expression with histological grade and lymph node status in breast carcinomas , 2002, Oncogene.

[66]  John Calvin Reed,et al.  The Patched dependence receptor triggers apoptosis through a DRAL–caspase-9 complex , 2009, Nature Cell Biology.

[67]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[68]  Barbara Stecca,et al.  Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals. , 2010, Journal of molecular cell biology.

[69]  Lee Niswander,et al.  Hedgehog signalling in the mouse requires intraflagellar transport proteins , 2003, Nature.

[70]  H. Phillip Koeffler,et al.  Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer , 2007, Breast Cancer Research and Treatment.

[71]  Joshua F. McMichael,et al.  Genome Remodeling in a Basal-like Breast Cancer Metastasis and Xenograft , 2010, Nature.

[72]  H. Tian,et al.  Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis , 2009, Proceedings of the National Academy of Sciences.

[73]  Z. Modrušan,et al.  Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance. , 2011, Cancer research.

[74]  G. Pazour,et al.  Primary Cilia Regulate Branching Morphogenesis during Mammary Gland Development , 2010, Current Biology.

[75]  Hua Li,et al.  Reciprocal Intraepithelial Interactions Between TP63 and Hedgehog Signaling Regulate Quiescence and Activation of Progenitor Elaboration by Mammary Stem Cells , 2008, Stem cells.

[76]  François Vaillant,et al.  Generation of a functional mammary gland from a single stem cell , 2006, Nature.

[77]  P. Cowin,et al.  Gli3-mediated repression of Hedgehog targets is required for normal mammary development , 2006, Development.

[78]  Z. Werb,et al.  Candidate regulators of mammary branching morphogenesis identified by genome‐wide transcript analysis , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[79]  M. Scott,et al.  Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors. , 1997, Cancer research.

[80]  C. Blanpain.  Tracing the cellular origin of cancer , 2013, Nature Cell Biology.

[81]  David Allard,et al.  Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer , 2009, Science.

[82]  P. Beachy,et al.  Interactions between Hedgehog proteins and their binding partners come into view. , 2010, Genes & development.

[83]  N. Pimpinelli,et al.  HEDGEHOG‐GLI Signaling Drives Self‐Renewal and Tumorigenicity of Human Melanoma‐Initiating Cells , 2012, Stem cells.

[84]  E. Dahl,et al.  Paradox of sonic hedgehog (SHH) transcriptional regulation: Alternative transcription initiation overrides the effect of downstream promoter DNA methylation , 2011, Epigenetics.

[85]  J. Trent,et al.  Identification of an amplified, highly expressed gene in a human glioma. , 1987, Science.

[86]  T. Shimokawa,et al.  Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists , 2007, Proceedings of the National Academy of Sciences.

[87]  M. Scott,et al.  Communicating with Hedgehogs , 2005, Nature Reviews Molecular Cell Biology.

[88]  J. Reiter,et al.  Primary cilia can both mediate and suppress Hedgehog pathway–dependent tumorigenesis , 2009, Nature Medicine.

[89]  Alicia Zhou,et al.  Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers , 2007, Proceedings of the National Academy of Sciences.

[90]  A. Álvarez-Buylla,et al.  Dual and opposing roles of primary cilia in medulloblastoma development , 2009, Nature Medicine.

[91]  E. Hafen,et al.  Dispatched, a Novel Sterol-Sensing Domain Protein Dedicated to the Release of Cholesterol-Modified Hedgehog from Signaling Cells , 1999, Cell.

[92]  Yutaka Shimada,et al.  Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours , 2003, Nature.

[93]  T. MacDonald,et al.  Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway. , 2011, The Journal of clinical investigation.

[94]  C. Rudin,et al.  Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors , 2011, Clinical Cancer Research.

[95]  A. Maitra,et al.  Urological Survey UROLOGICAL ONCOLOGY: PROSTATE CANCER Hedgehog Signalling in Prostate Regeneration, Neoplasia and Metastasis , 2005 .

[96]  Stephen C. Ekker,et al.  The product of hedgehog autoproteolytic cleavage active in local and long-range signalling , 1995, Nature.

[97]  J. Mullor,et al.  Pathways and consequences: Hedgehog signaling in human disease. , 2002, Trends in cell biology.

[98]  T. Curran,et al.  The Hedgehog's tale: developing strategies for targeting cancer , 2011, Nature Reviews Cancer.

[99]  S. O'toole,et al.  The Hedgehog signalling pathway as a therapeutic target in early breast cancer development , 2009, Expert opinion on therapeutic targets.

[100]  R. Ghirlando,et al.  The mode of Hedgehog binding to Ihog homologs is not conserved across different phyla , 2008, Nature.